CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise 10b5-1 | +10,427 | $29.82 | $311K | 26,613 |
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −10,427 | $53.73 | $560K | 16,186 |
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,932 | 53,337 | ||
| 2026-11-05 | Mara Joseph Anthony Jr Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,427 | 35,823 | ||
| 2026-11-05 | Flynn Sean C. Chief Legal Officer | Option exercise 10b5-1 | +15,000 | $16.25 | $244K | 16,990 |
| 2026-11-05 | Flynn Sean C. Chief Legal Officer | Sale 10b5-1 | −15,000 | $51.92 | $779K | 1,990 |
| 2026-11-05 | Flynn Sean C. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +15,000 | 40,000 | ||
| 2026-11-05 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise 10b5-1 | +1,500 | $34.90 | $52K | 2,759 |
| 2026-11-05 | SIEGAL JONATHAN Principal Accounting Officer | Sale 10b5-1 | −1,500 | $52.90 | $79K | 1,259 |
| 2026-11-05 | SIEGAL JONATHAN Principal Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +1,500 | 1,198 | ||
| 2026-11-05 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +500 | $13.05 | $7K | 33,495 |
| 2026-11-05 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −500 | $55.00 | $28K | 32,995 |
| 2026-11-05 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +2,500 | $13.05 | $33K | 35,495 |
| 2026-11-05 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,500 | $51.67 | $129K | 32,995 |
| 2026-11-05 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +500 | 4,500 | ||
| 2026-11-05 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 2,000 | ||
| 2026-11-04 | ZERBE ROBERT L MD Director | Option exercise 10b5-1 | +2,500 | $13.05 | $33K | 35,495 |
| 2026-11-04 | ZERBE ROBERT L MD Director | Sale 10b5-1 | −2,500 | $45.40 | $114K | 32,995 |
| 2026-11-04 | ZERBE ROBERT L MD Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 5,000 | ||
| 2026-08-12 | MCLAUGHLIN KEVIN F Director | Option exercise 10b5-1 | +7,000 | $13.05 | $91K | 25,300 |
Page 2 of 75 · 1,497 trades